Skip to Content

Tate & Lyle PLC

TATE: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
GBX 845.00ZfhgrpJnnrnqbt

Annual Results In Line, but Uninspiring Outlook

Sweetener and starch manufacturer Tate & Lyle reported in-line annual results to the end of March 2016, showing a 1% increase in constant-currency adjusted pretax profit, consistent with management's guidance for a similar level to the previous year. We are increasing our estimates for exceptional reasons: higher-than-expected proceeds from the sale of assets, driving debt levels down, and higher expected foreign exchange benefits from this year onwards, given Sterling's weakness in recent months. As a result, our fair value estimate increases 10% to GBX 550, but we are retaining our no-moat rating and its stable trend.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of TATE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center